Media Outlets Continue Coverage Of ‘London Patient,’ HIV Research Implications

Forbes: Second-Ever HIV Cure Seen In London AIDS Patient Is Rare, But It Might Not Have To Be (Mack, 3/5).

NBC News: Top HIV doctor says ‘London Patient’ cure ‘too risky’ to be feasible treatment (Fitzsimons, 3/5).

New York Times: An HIV Cure: Answers to 4 Key Questions (Mandavilli, 3/5).

NPR: Bone Marrow Transplant Renders Second Patient Free Of HIV (Harris, 3/5).

NPR: London Patient Cleared Of HIV (Greene/Harris, 3/5).

NPR: How Much Is Today’s HIV Research Centered Around The Search For A Cure? (Kelly, 3/5).

Popular Science: The treatment that cured two HIV cases won’t work for most patients (Wetsman, 3/5).

Reuters: U.S. AIDS activists welcome London ‘cure’ but warn against complacency (Ax, 3/5).

The Telegraph: From ignorance to a potential cure: the history of HIV breakthroughs (Gulland/Newey, 3/5).

U.N. News: U.N.’s AIDS agency ‘greatly encouraged’ by latest scientific breakthrough showing cure is possible (3/5).

USA TODAY: HIV patient seemingly cured in second remarkable case, London doctors report (May, 3/5).

Wired: The Gene Mutation That Could Cure HIV Has A Checkered Past (Molteni, 3/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.